Redeye notes that the Q2 report came in below our estimates on both sales and EBIT. STRAX still struggles as covid-related lockdowns affect retail sales negatively. As of now, we keep our estimates and valuation.
ANNONS
Redeye notes that the Q2 report came in below our estimates on both sales and EBIT. STRAX still struggles as covid-related lockdowns affect retail sales negatively. As of now, we keep our estimates and valuation.